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Abstract
Cotton GHB119 was developed by Agrobacterium tumefaciens-mediated transformation. It expresses
the Cry2Ae and phosphinothricin acetyltransferase (PAT) proteins which, respectively, confer resistance
to certain lepidopteran species and tolerance to glufosinate ammonium-based herbicides. The
molecular characterisation of cotton GHB119 did not give rise to safety issues. The agronomic,
phenotypic and compositional characteristics of cotton GHB119 tested under ﬁeld conditions revealed
no relevant differences between cotton GHB119 and its conventional counterpart that would give rise
to any food and feed or environmental safety concern. There were no concerns regarding the potential
toxicity and allergenicity of the newly expressed proteins Cry2Ae and PAT, and no evidence that the
genetic modiﬁcation might signiﬁcantly change the overall allergenicity of cotton GHB119. The
nutritional characteristics of cotton GHB119 are not expected to differ from those of non-GM cotton
varieties. There are no indications of an increased likelihood of establishment and spread of feral
cotton GHB119 plants. Considering the scope of this application, interactions with the biotic and abiotic
environment were not considered to be an issue. Risks associated with an unlikely but theoretically
possible horizontal gene transfer from cotton GHB119 to bacteria have not been identiﬁed. The
monitoring plan and reporting intervals are in line with the scope of the application. In conclusion, the
EFSA GMO Panel considers that the information available for cotton GHB119 addresses the scientiﬁc
comments raised by the Member States and that cotton GHB119, as described in this application, is as
safe as its conventional counterpart with respect to potential effects on human and animal health and
the environment in the context of the scope of this application.
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Summary
Following the submission of an application (EFSA-GMO-NL-2011-96) under Regulation (EC)
No 1829/2003 from Bayer CropScience AG, the Panel on Genetically Modiﬁed Organisms of the
European Food Safety Authority (GMO Panel) was asked to deliver a scientiﬁc opinion on the safety of
insect-resistant and herbicide-tolerant genetically modiﬁed (GM) cotton GHB119 (Unique Identiﬁer
BCS-GHØØ5-8). The scope of the application EFSA-GMO-NL-2011-96 is for import, processing, and
food and feed uses of cotton GHB119 within the European Union (EU), but excludes cultivation in the
EU.
The GMO Panel evaluated cotton GHB119 with reference to the scope and appropriate principles
described in its guidelines for the risk assessment of GM plants. The evaluation addressed the
following components of the risk assessment: the molecular characterisation of the inserted
DNA and analysis of the expression of the corresponding proteins; the comparative analyses
of compositional, agronomic and phenotypic characteristics; the safety of the newly expressed
proteins and the whole food/feed with respect to potential toxicity, allergenicity and nutritional
characteristics; and the environmental risk assessment and the post-market environmental
monitoring (PMEM) plan.
Cotton GHB119 was developed by Agrobacterium tumefaciens-mediated transformation. It
expresses the Cry2Ae and phosphinothricin acetyltransferase (PAT) proteins which, respectively,
confer resistance to certain lepidopteran species, and tolerance to glufosinate ammonium-based
herbicides. The molecular characterisation data establish that cotton GHB119 contains a single insert
consisting of a single copy of the T-DNA containing the cry2Ae and the bar expression cassettes. No
other parts of the plasmid used for transformation are present in cotton GHB119. Bioinformatic
analyses and genetic stability studies were performed and the results did not give rise to safety
issues. The levels of the newly expressed proteins present in cotton GHB119 were obtained and
reported adequately.
The agronomic, phenotypic and compositional characteristics of cotton GHB119 were compared
with those of the conventional counterpart Coker 312 under ﬁeld conditions. Differences were noted in
cotton GHB119 for several agronomic endpoints, but they did not give rise to any food and feed or
environmental safety concern. No differences requiring further assessment with regard to safety by the
GMO Panel were identiﬁed at analyses of compositional data of fuzzy cottonseeds from cotton
GHB119, except for the decreased levels of crude protein and tocopherols. As crude protein levels in
cotton GHB119 in some trials fell outside the range described in the OECD consensus document
(OECD, 2009), and as cottonseed is a relevant source of vegetable oil due to its high tocopherol
content, further food and feed nutritional assessment was performed and no safety concerns were
identiﬁed. The nutritional characteristics of food and feed derived from cotton GHB119 are not
expected to differ from that of food and feed derived from non-GM cotton varieties. The safety
assessment identiﬁed no concerns regarding the potential toxicity or allergenicity of the newly
expressed Cry2Ae and PAT proteins in cotton GHB119, and found no indications of a potentially
increased overall allergenicity of cotton GHB119 with respect to non-GM cotton. The GMO
Panel concludes that cotton GHB119 is as safe and nutritious as its conventional counterpart. The GMO
Panel considers that post-market monitoring of food/feed derived from cotton GHB119 is not
necessary, given the absence of safety concerns identiﬁed.
Application EFSA-GMO-NL-2011-96 covers the import, processing, and food and feed uses of cotton
GHB119, and excludes cultivation. Therefore, there is no requirement for a scientiﬁc assessment of
possible environmental effects associated with the cultivation of this GM cotton. The GMO
Panel concluded that there are no indications of an increased likelihood of establishment and spread of
feral cotton GHB119 plants in case of accidental release into the environment of viable GM cotton
seeds. Potential interactions with the biotic and abiotic environment were not considered to be an
issue by the GMO Panel. Risks associated with an unlikely but theoretically possible horizontal gene
transfer from cotton GHB119 to bacteria have not been identiﬁed. The PMEM plan provided by the
applicant is in line with the scope of the application and the requirements of the GMO Panel for PMEM
of GM plants. The GMO Panel agrees with the reporting intervals proposed by the applicant in the
monitoring plan.
In delivering its scientiﬁc opinion, the GMO Panel took into account the information presented in
application EFSA-GMO-NL-2011-96, additional information provided by the applicant, scientiﬁc
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comments submitted by the Member States and relevant scientiﬁc publications. In conclusion, the
GMO Panel considers that the information available for cotton GHB119 addresses the scientiﬁc
comments raised by the Member States and that cotton GHB119, as described in this application, is as
safe as its conventional counterpart with respect to potential effects on human and animal health and
the environment in the context of the scope of this application.
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1. Introduction
Cotton GHB119 was developed to confer resistance to certain lepidopteran pests and tolerance to
glufosinate ammonium-based herbicides. Resistance to pests, such as the cotton bollworm larvae
(CBW, Helicoverpa zea), tobacco budworm larvae (TBW, Heliothis virescens) and fall armyworm larvae
(FAW, Spodoptera frugiperda), is provided by the expression of the Cry2Ae protein, which has an
insecticidal effect on larvae of certain lepidopteran species. Tolerance to glufosinate ammonium-based
herbicides is achieved by the expression of phosphinothricin acetyltranferase (PAT), an enzyme that
acetylates L-glufosinate ammonium.
1.1. Background
On 7 April 2011, the European Food Safety Authority (EFSA) received from the Competent
Authority of the Netherlands an application, EFSA-GMO-NL-2011-96, for authorisation of genetically
modiﬁed (GM) cotton GHB119 for food and feed uses, import and processing submitted by Bayer
CropScience AG within the framework of Regulation (EC) No 1829/20031 on GM food and feed.
After receiving the application EFSA-GMO-NL-2011-96 and in accordance with Articles 5(2)(b) and
17(2)(b) of the Regulation (EC) No 1829/2003, EFSA informed the Member States and the European
Commission, and made the summary of the application publicly available on the EFSA website. EFSA
initiated a formal review of the application to check compliance with the requirements laid down in
Articles 5(3) and 17(3) of the Regulation (EC) No 1829/2003. On 30 August 2011 and 31 October
2011, EFSA received additional information requested under the completeness check (requested on 26
May 2011 and 19 September 2011, respectively). On 21 November 2011, EFSA declared the
application valid in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003.
EFSA made the valid application available to the Member States and the European Commission, and
consulted nominated risk assessment bodies of the Member States, including the national Competent
Authorities within the meaning of Directive 2001/18/EC2 following the requirements of Articles 6(4)
and 18(4) of Regulation (EC) No 1829/2003, to request their scientiﬁc opinion. The Member States
had 3 months after the opening of the Member State commenting period (until 21 February 2012) to
make their opinion known.
The GMO Panel carried out a scientiﬁc risk assessment of GM cotton GHB119. On 14 February
2012, 17 April 2012, 11 February 2013, 22 and 28 February 2013, 24 July 2013, 24 June 2015, 5
October 2015, 12 October 2015, 26 November 2015, 16 February 2016, 7 April 2016, 13 June 2016
and 3 August 2016, the GMO Panel requested additional information from the applicant. The applicant
provided the requested information on 21 May 2012, 4 July 2012, 13 March 2013, 5 April 2013, 2
March 2015, 9 July 2015, 11 November 2015, 30 November 2015, 23 December 2015, 4 April 2016,
16 June 2016, 29 June 2016 and 25 August 2016. After receipt and assessment of the full data
package, the GMO Panel ﬁnalised its risk assessment of cotton GHB119.
In giving its scientiﬁc opinion on cotton GHB119 to the European Commission, the Member States
and the applicant, and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003,
EFSA has endeavoured to respect a time limit of 6 months from the acknowledgement of the valid
application. As additional information was requested by the GMO Panel, the time limit of 6 months was
extended accordingly, in line with Articles 6(1), 6(2), 18(1) and 18(2) of Regulation (EC) No 1829/2003.
According to Regulation (EC) No 1829/2003, this scientiﬁc opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
1.2. Terms of Reference as provided by the requestor
The EFSA GMO Panel was requested to carry out a scientiﬁc assessment of cotton GHB119
(Gossypium hirsutum) for food and feed uses, import and processing in accordance with Articles 6(6)
and 18(6) of Regulation (EC) No 1829/2003.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
(PMM) requirements based on the outcome of the risk assessment and, in the case of GMOs
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
2 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the
environment of genetically modiﬁed organisms and repealing Council Directive 90/220/EEC. OJ L 106, 12.3.2001, p. 1–38.
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or food/feed containing or consisting of GMOs, conditions for the protection of particular ecosystems/
environments and/or geographical areas should be indicated in accordance with Articles 6(5)(e) and
18(5)(e) of Regulation (EC) No 1829/2003.
The EFSA GMO Panel was not requested to give an opinion on the information required under
Annex II to the Cartagena Protocol. Furthermore, the EFSA GMO Panel did not consider proposals for
labelling and methods of detection (including sampling and the identiﬁcation of the speciﬁc
transformation event in the food/feed and/or food/feed produced from it), which are matters related
to risk management.
2. Data and methodologies
2.1. Data
In delivering its scientiﬁc opinion, the GMO Panel took into account application EFSA-GMO-NL-2011-
96, additional information provided by the applicant, scientiﬁc comments submitted by the Member
States and relevant scientiﬁc publications.
2.2. Methodologies
The GMO Panel carried out a scientiﬁc risk assessment of cotton GHB119 for food and feed uses,
import and processing in accordance with Articles 6(6) and 18(6) of Regulation (EC) No 1829/2003. The
GMO Panel took into account the appropriate principles described in its guidelines for the risk assessment
of genetically modiﬁed (GM) plants and derived food and feed (EFSA, 2006a; EFSA GMO Panel, 2011a),
the environmental risk assessment of GM plants (EFSA GMO Panel, 2010) and on the post-market
environmental monitoring of GM plants (EFSA, 2006b; EFSA GMO Panel, 2011b).
The comments raised by the Member States are addressed in Annex G of EFSA’s overall opinion3
and were taken into consideration during the scientiﬁc risk assessment.
3. Assessment
3.1. Molecular characterisation
3.1.1. Evaluation of relevant scientiﬁc data
3.1.1.1. Transformation process and vector constructs
Cotton GHB119 was developed by Agrobacterium tumefaciens (also known as
Rhizobium radiobacter)-mediated transformation. The embryogenic calli of cotton (G. hirsutum) variety
Coker 312 were cocultured with a disarmed A. tumefaciens strain C58C1 containing the vector
pTEM12.4
The pTEM12 vector includes one T-DNA, which contains two gene cassettes:5 cry2Ae and bar.
The cry2Ae cassette, which confers insect resistance, contains the following genetic elements: the
Cauliﬂower Mosaic Virus 35S promoter (p35S2); the 50 leader sequence of the chlorophyll a/b binding
protein encoding gene from Petunia hybrida (50cab22L); the sequence encoding the transit peptide of
the ribulose-1,5-bisphosphate carboxylase small subunit from the gene ats1A of Arabidopsis thaliana
(TpssuAt); the codon-optimised cry2Ae sequence from Bacillus thuringiensis subsp. dakota 1715; and
the 30 untranslated region of the 35S transcript of the Cauliﬂower Mosaic Virus.
The bar cassette conferring tolerance to glufosinate ammonium contains the following genetic
elements: the promoter of Cassava Vein Mosaic Virus (Pcsvmv); the bar gene from Streptomyces
hygroscopicus strain ATCC 21705, coding for the PAT protein, with an altered amino acid (from Ser to
Asp) in the second codon6; and the 30 untranslated region of the nopaline synthase gene from the
T-DNA of pTiT37.
The vector backbone sequence contains the aminoglycoside adenyltransferase (aadA) gene
conferring bacterial resistance to spectinomycin; a fragment of the neomycin phosphotransferase gene
nptII; the origin of replication from the Escherichia coli plasmid pBR322; the origin of replication from
3 http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2011-00311
4 Dossier: Part I – Section C1.
5 Dossier: Part I – Section C2.
6 Dossier: Part I – Appendices (Report ID M-084188-01-2).
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the Pseudomonas plasmid pVS1; and the residual plasmid sequences from the A. tumefaciens plasmid
pTiAch5.
3.1.1.2. Transgene constructs in the genetically modiﬁed plant
Molecular characterisation of cotton event GHB119 was performed by Southern analysis and
sequencing of polymerase chain reaction (PCR)-ampliﬁed DNA fragments to determine copy number, size
and organisation of the inserted sequences, and to conﬁrm the absence of plasmid backbone sequence in
cotton GHB119.7 The approach used was acceptable both in terms of coverage and sensitivity.
Southern analysis with a set of eight restriction enzymes used individually or in combination,
together with seven distinct probes, indicated that the cotton event GHB119 contains a single insert,
which consists of a single copy of the T-DNA with the same conﬁguration as in the pTEM12
transformation vector. The absence of vector backbone was tested by Southern analysis, using six
overlapping probes.8
The insert and 1,019 bp and 1,026 bp of the 50 and 30 ﬂanking regions of cotton GHB119,
respectively, were sequenced. The insert of 4,302 bp is identical to the T-DNA of pTEM12. The
sequencing of the pre-insertion locus was determined, and the comparison of its sequence to the
sequence of the 50 and 30 ﬂanking regions of cotton GHB119 showed that a deletion of 8 bp of plant
DNA occurred at the insertion site as a result of the transformation.9 The possible interruption of
known endogenous cotton genes by the insertion in GHB119 was evaluated by bioinformatic analyses
of the pre-insertion locus and of the genomic sequences ﬂanking the insert.10 The results from these
analyses did not indicate the interruption of any known endogenous gene in cotton GHB119 and,
together with results of segregation (see Section 3.1.1.4), established that the insert is located in the
nuclear genome.
Updated bioinformatic analyses11 of the amino acid sequence of the newly expressed Cry2Ae and
PAT proteins revealed no signiﬁcant similarities to toxins or allergens. Using an 80-amino acids sliding
window approach, no signiﬁcant similarity over 35% identity with known allergens was found for the
Cry2Ae and PAT proteins. In addition, updated bioinformatic analyses11 of the newly created open
reading frames (ORFs) within the insert and at its junction sites indicate that expression of an ORF
showing signiﬁcant similarities to toxins and allergens is highly unlikely.
3.1.1.3. Information on the expression of the insert
Levels of the Cry2Ae and PAT proteins were analysed by enzyme-linked immunosorbent assay
(ELISA) from cottonseeds of cotton GHB119 harvested from six locations in the USA in 2006 and from
six locations in Spain in 2007. Samples analysed were obtained from plants treated with glufosinate
ammonium-based herbicides or only with conventional herbicides.12 The mean values and ranges of
protein expression levels in cottonseeds of the Cry2Ae and PAT proteins are summarised in Table 1.
Table 1: Mean, standard deviation (upper row) and ranges (lower row) of Cry2Ae and PAT protein
levels in cotton GHB119 (lg/g fresh weight)
Field trial year (location)
Cry2Ae PAT
Treated(a) Untreated(b) Treated(a) Untreated(b)
2006 (USA)
n* = 54
1.47  0.07 1.55  0.19 49.9  3.5 50.7  4.1
1.38–1.57 1.30–1.81 45.5–56.1 44.5–54.9
2007 (Spain)
n = 36
3.26  0.45 3.18  0.32 117  25 114  25
2.80–3.81 2.75–3.55 96.9–158 86.8–152
PAT: phosphinothricin acetyltransferase.
*n – number of samples tested
(a): Cotton GHB119 treated with glufosinate ammonium-based herbicides.
(b): Cotton GHB119 treated only with conventional herbicides.
7 Dossier: Part I – Section D2.
8 Dossier: Part I – Section D2 (a).
9 Dossier: Part I – Section D2 (c).
10 Dossier: Part I – Section D2 (b).
11 Additional information: 16/6/2016.
12 Dossier: Part I – Section D3 (a), (b) and (d).
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3.1.1.4. Inheritance and stability of inserted DNA
Genetic stability of the GHB119 insert was studied by Southern analysis. Samples represented three
generations grown at six different ﬁeld locations. The restriction enzyme/probe combinations used
were sufﬁcient to conclude that all the plants tested retained the single copy of the insert and ﬂanking
regions, which were stably inherited in multiple generations.13
Phenotypic stability was observed by segregation analysis of the herbicide tolerance trait in plants
from the F1 generation of a cross between GHB119/T0 plants with three conventional genetic
backgrounds and from F2 generation resulting from self-pollination of the F1 plants. The results
supported the presence of a single insertion, segregating in a Mendelian fashion.
3.1.2. Conclusion on molecular characterisation
The molecular characterisation data establish that cotton GHB119 contains a single insert consisting
of one copy of the cry2Ae and bar expression cassettes. Bioinformatic analyses of the sequences
encoding the newly expressed proteins and of other ORFs present within the insert or spanning the
junction sites between the insert and genomic DNA did not give rise to safety issues. The stability of
the inserted DNA and of the herbicide tolerance traits was conﬁrmed over several generations. The
levels of the Cry2Ae and PAT proteins were obtained and reported adequately.
3.2. Comparative analysis
3.2.1. Evaluation of relevant scientiﬁc data
3.2.1.1. Choice of comparator and production of material for the comparative analysis14
Application EFSA-GMO-NL-2011-96 presents data on cottonseed composition of cotton GHB119
derived from ﬁeld trials performed at six sites in the USA15 in the 2006 growing season and in Spain
during two growing seasons, 2007 and 2008 (Table 2). The Spanish ﬁeld trials were also used for the
agronomic and phenotypic characterisation (Table 2). As indicated in Section 3.1.1.1, GM cotton
GHB119 was obtained by transforming cotton variety Coker 312. In these ﬁeld trials, Coker 312 was
used as a comparator. The GMO Panel considers that this non-transgenic line is the appropriate
conventional counterpart, as it has the same genetic background as the cotton line of cotton GHB119.
The USA 2006 ﬁeld trials included cotton GHB119 treated with glufosinate ammonium-based
herbicides, cotton GHB119 treated only with conventional herbicides and the conventional counterpart
(Coker 312) treated with conventional herbicides. In each location, a randomised complete block
design with three replications of each material was applied.
Table 2: Overview of comparative assessment studies with cotton GHB119 and its conventional
counterpart Coker 312 provided in application EFSA-GMO-NL-2011-96.
Study details
(year, country/region)
Field trial sites
Total number of sites
Sites used for
agronomic and
phenotypic
characteristics
Sites used for
compositional
analysis
2006, USA 6 None 6
2007, Spain (Andalusia) 6 6 6
2007, Spain (Catalonia) 12 12 None
2008, Spain (Andalusia) 6 6 6
2008, Spain (Catalonia) 8 8 None
Aggregate studies in Spain
(2007/2008, Andalusia/Catalonia) 32 32 12
13 Dossier: Part I – Section D5.
14 Dossier: Part I – Section D7.2.
15 Arkansas (two sites), Georgia (one site), Mississippi (one site) and Texas (two sites).
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In order to investigate additional characteristics of the GM cotton GHB119, pollen morphology and
germination were investigated, as well as the overwintering capacity of the cottonseeds of cotton GHB119.
The Spanish ﬁeld trials were carried out in the regions of Catalonia (12 sites in 2007 and eight in
2008) and Andalusia (six sites in 2007 and six in 2008). In each site, a randomised complete block
design was used with three replications of the following materials: cotton GHB119 treated with
glufosinate ammonium-based herbicides, cotton GHB119 treated only with conventional herbicides and
the conventional counterpart treated with conventional herbicides. Non-GM commercial reference
varieties were also included in each location.16
Data for agronomic and phenotypic traits were collected from all the 32 ﬁeld trials in Spain, while
the 12 sites from Andalusia (2007/2008) were used for the compositional analysis. Initially, four
Catalonian sites (out of 20 in total) were also included in the compositional analysis; however, the
selection criteria for those sites were considered not acceptable by the GMO Panel.17
3.2.1.2. Agronomic and phenotypic characteristics18
The agronomic and phenotypic characteristics collected from the 32 ﬁeld trial sites in Spain (Table 2)
included plant morphology characteristics,19 parameters related to agronomic performances,20
interactions with biotic stressors21 and ﬁbre properties.22
The data were analysed with analysis of variance (ANOVA), in order to test for differences between
cotton GHB119 and its conventional counterpart Coker 312.23,24 Statistically signiﬁcant differences
between cotton GHB119 (treated with glufosinate ammonium-based herbicides, ‘treated’, or treated
only with conventional herbicides, ‘untreated’) and its conventional counterpart (Coker 312) treated
with conventional herbicides were identiﬁed for all the measured endpoints except for short ﬁbre index
(between cotton GHB119 untreated and Coker 312) and for ﬁbre elongation (between cotton GHB119
treated and Coker 312). The potential environmental impact of the observed differences is discussed in
Section 3.4.1.1.
The differences in the ﬁbre parameters, such as length, strength and micronaire, did not lead to a
different classiﬁcation of the ﬁbre quality. The differences in endpoints related to insect damage and
presence of insect larvae were expected since cotton GHB119 expresses the insecticidal Cry2Ae
protein. The potential environmental impact of the observed difference is discussed in Section 3.4.1.1.
In addition, an overwintering study with cotton GHB119 in comparison to Coker 312 was performed
in a single location (Lubbock, Texas) in the USA. Seeds produced in 2008 were sampled and
subsequently incubated over winter underground. After 7 months, the seeds were inspected and
analysed for their viability. The data indicated that cottonseeds derived from cotton GHB119 as well as
from Coker 312 do not remain viable after overwintering for 7 months.
Agronomic and phenotypic characteristics tested under controlled conditions25
Pollen germinability and viability from cotton GHB119 and its conventional counterpart (Coker 312)
were measured according to Barrow (1981). Pollen was obtained from plants grown under greenhouse
conditions in 2007. The pollen germinability was tested between 0 and 78 h after its collection. The
applicant observed no statistically signiﬁcant differences between cotton GHB119 and its conventional
counterpart for pollen germinability and viability.
While Barrow’s test provides an indication of the germination capacity, it does not measure pollen
viability directly as germination is forcefully induced. Therefore, the data on pollen viability supplied by
the applicant in support of the comparative assessment of cotton GHB119 are not considered suitable
16 In the Catalonian ﬁeld trials, two commercial non-GM varieties were included at each location; in the Andalusian ﬁeld trials,
four commercial non-GM varieties were included at each location.
17 Additional information: 4/4/2016.
18 Dossier: Part I – Section D4 and D7.4.
19 Measured plant morphology characteristics: plant height, developed nodes, ﬁrst bolls position and total number of bolls.
20 Measured agronomic performances: seed cotton yield, stand count, ﬁbre yield, number of seed/10 bolls, weight fuzzy seed/10
bolls, total bolls, number of days to ﬁrst ﬂower and number of days to ﬁrst boll.
21 Biotic stressors: number of damaged square, ﬂower and boll per 20 plants each at date 1 and 2 produced by insects and by
living larvae, and damage by insects at date 2.
22 Fibre properties: ﬁbre ﬁneness – micronaire, ﬁbre length, ﬁbre length uniformity, short ﬁbre index, ﬁbre strength and ﬁbre
elongation.
23 Additional information: 4/7/2012.
24 A linear model was used, with the ﬁxed factors regimen (each of the three materials), region (Andalusia/Catalonia), season
(2007/2008) and site, and terms for the interaction of regimen with the other factors.
25 Dossier: Part I – Section D4.
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by the GMO Panel. Given that the genetic modiﬁcation of cotton GHB119 is not designed to target
speciﬁc pollen and seed characteristics, that cotton is not a persistent and invasive crop, and that the
scope of cotton GHB119 excludes cultivation, the GMO Panel considers that data on pollen viability are
not essential for the risk assessment of cotton GHB119.
3.2.1.3. Compositional analysis26
Fuzzy cottonseeds from the USA ﬁeld trials in 2006 (Table 2) were analysed for proximates, ﬁbre
fractions, amino acids, fatty acids, vitamin E, minerals and anti-nutrients.27 The choice of the
compounds followed the recommendations of the OECD consensus document (OECD, 2009).
The data for compositional analysis from the ﬁeld trials in the USA in 2006 were analysed with
ANOVA,28 in order to test for differences between cotton GHB119 and its conventional counterpart
Coker 312. The statistical analysis identiﬁed 24 signiﬁcant differences between cotton GHB119 (treated
with glufosinate ammonium-based herbicides) and its conventional counterpart, and 23 signiﬁcant
differences between cotton GHB119 (treated only with conventional herbicides) and its conventional
counterpart (Table 3).
Table 3: Compositional endpoints (USA ﬁeld trials, 2006) for which signiﬁcant differences were
found between cotton GHB119 and its conventional counterpart Coker 312
Component
cotton GHB119 Conventional counterpart
(Coker 312)Treated(a) Untreated(b)
Moisture (% FW) 9.99* 10.14 10.57
Crude protein (% DM) 20.01* 20.67* 23.06
Total carbohydrates (% DM) 57.32* 56.26* 54.29
Zinc (mg/kg DM) 36.2* 35.3 34.0
a-tocopherol (mg/kg DM) 118* 121* 128
Alanine (% AA) 4.43* 4.45* 4.35
Arginine (% AA) 11.09* 10.97* 11.59
Glutamic acid (% AA) 20.77* 20.66* 21.01
Glycine (% AA) 4.64* 4.65* 4.58
Histidine (% AA) 3.08* 3.08* 3.04
Leucine (% AA) 6.54* 6.55* 6.44
Lysine (% AA) 5.19* 5.22* 5.05
Proline (% AA) 4.11 4.17* 4.08
Serine (% AA) 5.06* 5.08* 4.87
Threonine (% AA) 3.63* 3.66* 3.51
Tyrosine (% AA) 2.84* 2.85* 2.74
Myristic acid (C14:0) (% FA) 0.82* 0.81* 0.76
Stearic acid (C16:0) (% FA) 2.47* 2.47* 2.36
Oleic acid (C18:1) (% FA) 18.41* 18.28* 15.68
Linoleic acid (C18:2) (% FA) 52.53* 52.67* 55.53
Arachidic acid (C20:0) (% FA) 0.29* 0.30* 0.28
Free gossypol (% DM) 0.530* 0.538* 0.642
Total gossypol (% DM) 0.618* 0.613* 0.714
26 Dossier: Part I – Section D7.3; additional information: 4/7/2012, 2/3/2015, 9/7/2015 and 4/4/2016.
27 Proximates and ﬁbre compounds included moisture, crude protein, crude fat, ash, total carbohydrates, acid detergent ﬁbre
(ADF) and neutral detergent ﬁbre (NDF); minerals included calcium, phosphorus, potassium, magnesium, iron and zinc;
vitamin E compounds included a-tocopherol, b-tocopherol, c-tocopherol, d-tocopherol and total tocopherols; amino acids
included alanine, arginine, aspartic acid, cystine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine,
phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine; fatty acids included myristic (C14:0), palmitic
(C16:0), margaric (C17:0), stearic (C18:0), arachidic (C20:0), behenic (C22:0), lignoceric (C24:0), palmitoleic (C16:1), oleic
(C18:1), linoleic (C18:2) and linolenic (C18:3); antinutrients included free and total gossypol, phytic acid and the
cyclopropenoid fatty acids sterculic, malvalic and dihydrosterculic.
28 A linear model was used, with the ﬁxed factors regimen (each of the three materials) and site, and terms for the interaction
of regimen with the other factors.
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Fuzzy cottonseeds from the ﬁeld trials carried out in Andalusia in 2007 and 2008 (Table 2) were
analysed for proximates and ﬁbre, minerals, amino acids, fatty acids, vitamin E and antinutrients.29
The choice of the compounds followed the recommendations of the OECD consensus document
(OECD, 2009).
The data were analysed with ANOVA, in order to test for differences between cotton GHB119 and
its conventional counterpart Coker 312.17,30 The statistical analysis identiﬁed 29 signiﬁcant differences
between cotton GHB119 (treated with glufosinate ammonium-based herbicides) and its conventional
counterpart, and 32 signiﬁcant differences between cotton GHB119 (treated only with conventional
herbicides) and its conventional counterpart (Table 4).
Component
cotton GHB119 Conventional counterpart
(Coker 312)Treated(a) Untreated(b)
Dihydrosterculic acid (% FA) 0.193* 0.198* 0.15
Phytic acid (% DM) 1.38* 1.39* 1.44
FW: fresh weight; DM: dry matter; FA: total fatty acids; AA: total amino acid.
The values shown are estimated means. Signiﬁcantly different entries for the GM cotton are marked with an asterisk.
The EFSA GMO Panel noted that the free gossypol content in raw cottonseeds of cotton GHB119 and its conventional counterpart
was higher than the limits set in Directive 2002/32 EC (5,000 mg/kg as fed) on undesirable substances in feed materials.
(a): Cotton GHB119 treated with glufosinate ammonium-based herbicides.
(b): Cotton GHB119 treated only with conventional herbicides.
Table 4: Compositional endpoints (ﬁeld trials in Andalusia, Spain, 2007/2008) for which signiﬁcant
differences were found between cotton GHB119 and its conventional counterpart Coker
312.
Component
cotton GHB119 Conventional counterpart
(Coker 312)Treated(a) Untreated(b)
Moisture (% FW) 9.23* 9.11 8.95
Crude protein (% DM) 23.5* 23.5* 27.8
Crude fat (% DM) 23.4* 22.9* 21.5
Ash (% DM) 3.98* 3.92* 4.11
ADF (% DM) 39.8* 39.8* 38.7
NDF (% DM) 48.9* 49.7* 46.5
Total carbohydrate (% DM) 49.1* 49.6* 46.5
Phosphorous (% DM) 0.56 0.53* 0.56
Magnesium (% DM) 0.369* 0.380* 0.445
Iron (mg/kg DM) 45.2* 45.7* 52.5
Zinc (mg/kg DM) 33.7* 35.8* 40.2
Total tocopherol (a-toc. equiv.) (mg/kg DM) 101.7* 107.0* 114.0
Alanine (% AA) 4.18* 4.13* 4.00
Arginine (% AA) 11.55* 11.57* 12.42
Leucine (% AA) 6.29* 6.26* 6.16
Lysine (% AA) 5.07* 5.02* 4.92
Serine (% AA) 3.65 3.72* 3.58
29 Proximates and ﬁbre compounds included moisture, crude protein, crude fat, ash, total carbohydrates, acid detergent ﬁbre
(ADF) and neutral detergent ﬁbre (NDF); minerals included calcium, phosphorus, potassium, magnesium, iron and zinc; anti-
nutrients included free gossypol, total gossypol, phytic acid, malvalic acid, sterculic acid and dihydrosterculic acid; vitamin E
compounds included total tocopherol; amino acids included alanine, arginine, aspartic acid, cystine, glutamic acid, glycine,
histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine;
fatty acids included myristic (C14:0), pentadecanoic (C15:0), palmitic (C16:0), palmitoleic (C16:1, x-7), palmitoleic (C16:1, x-
9), heptadecanoic (C17:0), stearic (C18:0), oleic (C18:1) cis isomer, oleic (C18:1), linoleic (C18:2), linoleic (C18:2) trans
isomer, a-linolenic (C18:3), arachidic (C20:0), gadoleic (C20:1), behenic (C22:0) and lignoceric (C24:0).
30 A linear model was used, with the ﬁxed factors regimen (each of the three materials), season (2007/2008) and site, and
terms for the interaction of regimen with the other factors.
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Based on the well-known biochemical role of the compounds in Tables 3 and 4 and on the reported
ranges of natural variation described in the OECD consensus document (OECD, 2009) and published in
the literature (e.g. Berberich et al., 1996), the GMO Panel identiﬁed no need for further assessment
with regard to food and feed safety, except for crude protein and tocopherols.
Crude protein content in cotton GHB119 was reduced compared to its conventional counterpart in
both ﬁeld trial studies (Tables 3 and 4), and in the USA ﬁeld trials it fell outside the range (21.8–34.2%
DM) described in the literature (OECD, 2009). Crude protein content is considered for further
nutritional assessment in Section 3.3.1.4.
Considering that cottonseed is a relevant source of vegetable oil due to its high tocopherol content,
the reduced levels of tocopherols in cotton GHB119 compared to its conventional counterpart are
considered for further nutritional assessment Section 3.3.1.4.
3.2.1.4. Effect of processing31
Processed products
Based on the outcome of the comparative assessment, processing of the cotton GHB119 into food
and feed products is not expected to result in products being different from those of commercial non-
GM cotton varieties.
Compositional data were obtained on processed products of ginned cottonseeds from an additional
ﬁeld trial carried out at one site in Argentina in 2008.32 In this ﬁeld trial, cottonseed samples of cotton
GHB119 and Coker 31533 treated with glufosinate ammonium-based herbicides were harvested and
processed, at a pilot processing plant simulating industrial practice, into cotton products, including
delinted seeds, hulls, meal (heated, ﬂaked and extruded, solvent extraction), toasted meal, crude oil
and reﬁned bleached deodorised (RBD) oil.
Delinted seeds, meal and toasted meal were analysed for proximates, ﬁbre, amino acids, minerals,
a-tocopherol, free and total gossypol, cyclopropenoid fatty acids and phytic acid. Delinted seeds were
Component
cotton GHB119 Conventional counterpart
(Coker 312)Treated(a) Untreated(b)
Threonine (% AA) 3.14* 3.14* 3.03
Tryptophan (% AA) 1.46 1.51* 1.41
Tyrosine (% AA) 2.58* 2.59* 2.39
Myristic acid (C14:0) (% FA) 0.89* 0.88* 0.85
Palmitic acid (C16:0) (% FA) 23.05* 23.20 23.38
Palmitoleic acid (C16:1, x-7) (% FA) 0.64* 0.63* 0.59
Oleic acid (C18:1) (% FA) 19.92* 20.07* 17.75
Oleic acid (C18:1) (cis-isomer) (% FA) 0.97* 0.96* 1.02
Linoleic acid (C18:2) (% FA) 49.38* 49.27* 51.64
Linoleic acid (C18:2) (trans-isomer) (% FA) 0.046 0.043* 0.046
a-linolenic acid (C18:3) (% FA) 0.160 0.152* 0.162
Arachidic acid (C20:0) (% FA) 0.328* 0.318* 0.304
Behenic acid (C22:0) (% FA) 0.125* 0.116* 0.106
Lignoceric acid (C24:0) (% FA) 0.075 0.072* 0.078
Total gossypol (% DM) 0.75* 0.71 0.71
Malvalic acid (% FA) 0.48* 0.46* 0.43
Sterculic acid (% FA) 0.25* 0.25* 0.19
Dihydrosterculic acid (% FA) 0.27* 0.26* 0.19
FW: fresh weight; DM: dry matter; ADF: acid detergent ﬁbre; NDF: neutral detergent ﬁbre; AA: total amino acid; FA: total fatty acids.
The values shown are estimated means. Signiﬁcantly different entries for the GM cotton are marked with an asterisk.
(a): Cotton GHB119 treated with glufosinate ammonium-based herbicides.
(b): Cotton GHB119 treated only with conventional herbicides.
31 Dossier: Part I – Section D7.6.
32 Dossier: Part I – Section D7.6.
33 Coker 315 has a very similar genetic background to Coker 312, hence it is considered an appropriate conventional counterpart
for cotton GHB119; additional information: 4/7/2012.
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also analysed for fatty acids. Hulls were analysed for proximates and ﬁbre; crude and reﬁned oils were
analysed for fatty acids, tocopherols, total gossypol and cyclopropenoid fatty acids. All cottonseed
fractions of cotton GHB119 showed lower protein content compared to its conventional counterpart.34
The levels of cyclopropenoid fatty acids were lower in all feed fractions derived from cotton GHB119,
including crude and RBD oil.
In the same processing study, the levels of the newly expressed proteins Cry2Ae and PAT were
measured and detected in cotton GHB119-derived fractions but not in those from Coker 315. Cry2Ae
and PAT were detectable in delinted cottonseeds, cottonseed meal (at very low levels in toasted meal)
and hulls, but not detectable in crude and RBD oil from cotton GHB119.35
The values obtained for the composition of products derived from cotton GHB119 were similar to
those of its conventional counterpart Coker 315 and within the values reported in literature (e.g.
Forster and Calhoun, 1995; OECD, 2009).
Newly expressed proteins
Effect of temperature on newly expressed protein. The thermal stability of the bacterial Cry2Ae protein
was evaluated after protein exposure at temperatures of 60, 75 and 90°C for periods of 10, 30 and 60 min,
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by Coomassie blue
staining and western blot analyses. No signiﬁcant changes in the Cry2Ae protein band intensity were
observed after incubation at 60°C up to 60 min; a slight decrease in the Cry2Ae protein band intensity was
observed after incubation at 75°C up to 60 min and at 90°C for 10 min; the Cry2Ae protein band intensity
was markedly decreased after incubation at 90°C for 30 min, disappearing after 60 min.36 The thermal
stability of the Cry2Ae protein was also assessed in a bioassay conducted on a target insect species
(Heliothis zea). After exposure of the Cry2Ae protein for 5, 10, 30, 60, 120, 240 min and overnight to
temperatures of 45°C and 60°C, the protein was fed to H. zea to assess its activity. While the Cry2Ae protein
remained stable at 45°C even during overnight incubation, the activity started decreasing after 60 min at
60°C, continuing to decrease with longer incubation times, up to sixfold after incubation over 240 min.37
3.2.2. Conclusion
The GMO Panel concluded that the differences identiﬁed in the agronomic and phenotypic
characteristics between cottonseed GHB119 and its conventional counterpart did not require further
assessment for food and feed safety. The differences are further assessed for their potential
environmental impact in Section 3.4.1.1.
The differences identiﬁed between cotton GHB119 and its conventional counterpart in fuzzy
cottonseed levels of crude protein and total tocopherol are further assessed in Section 3.3.1.4. The
GMO Panel concluded that none of the other differences identiﬁed in the composition of fuzzy
cottonseeds necessitated further assessment regarding food and feed safety.
The GMO Panel concluded that the compositional differences identiﬁed between products derived
from cotton GHB119 and from its conventional counterpart did not require further assessment for food
and feed safety.
3.3. Food/Feed safety assessment
3.3.1. Evaluation of relevant scientiﬁc data
3.3.1.1. Toxicology38
Cotton GHB119 expresses two new proteins, Cry2Ae and PAT (Section 3.1.1).
Proteins used for safety assessment
Given the technical restraints in producing large enough quantities for safety testing from plants,
the Cry2Ae protein was recombinantly produced in B. thuringiensis. The puriﬁed protein from the
34 Signiﬁcantly different protein levels (in percentage dry matter (% DM), cotton GHB119 vs Coker 315) were as follows: 22.9 vs
25.8% DM in delinted cottonseed; 7.3 vs 8.1% DM in hulls; 33.2 vs 39.8% DM in cottonseed meal; 34.9 vs 38.7% DM in
toasted cottonseed meal.
35 Dossier: Part I – Section D7.7.
36 Dossier: Part I – Section D7.8.1.
37 Additional information: 2/3/2015.
38 Dossier: Part I – Section D7.8.
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bacterial source and from cotton GHB119 were characterised and compared in terms of their
physicochemical, structural and functional properties.
a) Cry2Ae characterisation and equivalence. SDS-PAGE and western blot analysis showed that
plant- and microbe-derived Cry2Ae proteins39 had the expected molecular weight of ~ 71 kDa and
were similarly immunoreactive to the Cry2Ae protein speciﬁc antibodies. Glycosylation detection
analysis conﬁrmed the absence of glycosylation for the Cry2Ae protein from cotton GHB119. Amino
acid sequence analysis by liquid chromatography/mass spectrometry suggested that both plant- and
microbe-derived proteins matched their expected sequence. At the N-terminus, the transit peptide of
the plant form was cleaved at the expected residue. Functional equivalence was demonstrated by an
insect bioassay and showed that both plant- and microbe-derived proteins had comparable biological
activity. In addition, to justify the appropriateness of the recombinant protein batch used in the new
28-day oral toxicity study in mice40 provided upon request of the GMO Panel, a comparison of this
batch with the microbial Cry2Ae batch used in the original 28-day study41 was provided; physical and
chemical properties of the two batches were comparable.42 SDS-PAGE and western blot analysis
showed that microbe-derived Cry2Ae proteins from both batches had the expected molecular weight of
~ 71 kDa and were similarly immunoreactive to the Cry2Ae protein speciﬁc antibodies. The absence of
glycosylation was conﬁrmed. Amino acid sequence analysis by liquid chromatography/mass
spectrometry and the N-terminal sequence obtained for both Cry2Ae protein batches were consistent
with the theoretical amino acid sequence for the Cry2Ae protein.
Based on these data, the GMO Panel accepts the use of the Cry2Ae protein derived from
B. thuringiensis in the safety studies.
b) PAT characterisation. SDS-PAGE and western blot analysis showed that the plant-derived PAT
protein had the expected molecular weight of ~ 21 kDa and was immunoreactive to the PAT protein
speciﬁc antibodies. Glycosylation detection analysis conﬁrmed the absence of glycosylation. Sequence
analysis by mass spectrometry and N-terminal sequencing showed that the protein matched its
expected sequence. These data also showed that the ﬁrst ﬁve amino acids from the N-terminus could
not be determined. In contrast, the C-terminus fully matched the expected sequence. The enzymatic
activity of the plant PAT protein was determined using a biochemical in vitro assay.
Toxicological assessment of newly expressed proteins
The PAT protein has been previously assessed by the GMO Panel (e.g. EFSA, 2006c; EFSA GMO
Panel, 2013) and no safety concerns for humans and animals were identiﬁed. Updated bioinformatics
analysis did not reveal similarities of the PAT protein to known toxins.43 The GMO Panel is not aware of
any new information that would change these conclusions. The GMO Panel concludes that the PAT
protein does not raise safety concerns.
The Cry2Ae protein has never been assessed by the GMO Panel.
a) Bioinformatic studies43
Bioinformatic analyses of the amino acid sequences of the Cry2Ae protein expressed in cotton GHB119
revealed no relevant similarities to known proteins toxic to humans and animals (Section 3.1.1.2).
b) In vitro degradation studies44
The resistance of the Cry2Ae protein to degradation by pepsin was studied in solutions at pH 1.2.
The integrity of the test protein in samples of the incubation mixture taken at various time points was
analysed by SDS-PAGE gel electrophoresis followed by protein staining or by western blotting. No
intact Cry2Ae protein was observed at the 5 min incubation time point. Low molecular weight
fragments of 3–5 kDa in the protein-stained SDS-PAGE gel completely disappeared after 10 min of
incubation. By western blot analysis, these fragments were not immunologically reactive to a polyclonal
antibody against Cry2Ae.
The GMO Panel has previously evaluated the in vitro degradation study submitted to support this
application (EFSA-GMO-NL-2011-96) and the safety of the PAT protein in the context of other
applications (e.g. EFSA, 2006c; EFSA GMO Panel, 2013).
39 Cry2Ae batches NB210806P25 and VMLV1041-1.
40 Batch 1410_Cry2Ae.
41 Batch VMLV1041-1.
42 Additional information: 23/12/2015.
43 Additional information: 16/6/2016.
44 Dossier: Part I – Section 7.9.1; additional information: 2/3/2015.
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c) Acute oral toxicity testing45
A bacterial-derived Cry2Ae protein was administrated by oral gavage at a dose of 2,000 mg/kg
body weight (bw) to male and female OF1 mice. No effects related to the Cry2Ae protein
were observed.
The GMO Panel is of the opinion that acute toxicity testing of the newly expressed proteins is of
little additional value for the risk assessment of the repeated consumption of food and feed from GM
plants by humans and animals.
d) 28-day repeated dose toxicity study
In the original application, the applicant provided a 28-day oral toxicity study in mice with the
Cry2Ae protein.45 The study was not accepted by the GMO Panel due to several limitations.46 Upon
request of the GMO Panel, the applicant provided a new 28-day oral toxicity study in mice with the
recombinant Cry2Ae protein37 described above. The study was conducted in alignment with OECD TG
40747; however, the GMO Panel noted that analysis of coagulation and bile acids was not performed.
The study was in compliance with the principles of Good Laboratory Practice (GLP).
Groups of singly caged C57BL/6J mice (10/gender per group) were administered by gavage
(20 mL/kg bw) the Cry2Ae protein at a targeted nominal dose of 1,000 mg/kg bw per day or the
vehicle alone (control group). Both feed and water were provided ad libitum. During the study, all
animals were checked at least daily for mortality or general clinical signs. Detailed physical
examinations were performed at least weekly. Body weights and feed consumption were recorded at
least weekly. Ophthalmoscopy was carried out before the start and at the end of the treatment. On
study days 25 and 29, blood samples were taken for haematological and clinical chemistry analyses,
respectively (animals were fasted overnight for the latter). At the end of the treatment period, all
animals were sacriﬁced and underwent a detailed necropsy examination with selected organs weighed.
Organs and tissues from all animals from the Cry2Ae-treated and control groups were subjected to a
comprehensive histological examination. Descriptive statistics were calculated for each group and per
time period for body weight change parameters, and for average food consumption per day
parameters. All the endpoints were tested for homogeneity of variance with an F-test (a = 0.05). The
group means were then compared either with a t-test (if the F-test was not signiﬁcant) or with a
modiﬁed t-test (if the F-test was signiﬁcant). For body weight and average food consumption per day
parameters, in case the initial F-test was signiﬁcant, the analysis was repeated on transformed data
(log or square root transformation).
One female mouse given the Cry2Ae protein was found dead on day 26 of the study. This mouse
showed at necropsy an abscess with skin ulceration in the ventral axillary area, microscopically
associated with skin ulcerative and necrotising inﬂammation, and an enlarged spleen. These lesions
were considered incidental in the study report. No clinically relevant ﬁndings or ophthalmic changes
were observed. Statistically signiﬁcantly lower body weight and cumulative body weight gain were
seen on study day 22 in females given the Cry2Ae protein compared to the female controls; since this
ﬁnding was transient and the ﬁnal body weight did not differ, this was not considered toxicologically
relevant. There were no statistically signiﬁcant differences in haematology parameters in male
animals. Females given the Cry2Ae protein, when compared to their controls, showed signiﬁcantly
lower red blood cell counts (10.08  0.23 vs 10.33  0.24 9 1012/L), haemoglobin concentration
(15.40  0.3 vs 15.92  0.35 g/dL) and mean corpuscular haemoglobin concentration (29.32  0.41
vs 29.75  0.34 g/dL). The differences were minimal, not associated with changes in related
parameters (e.g. reticulocyte count, spleen weight, gross pathology and histopathology, bone marrow
histopathology) and were therefore considered not toxicologically relevant by the GMO Panel.
Regarding clinical chemistry parameters, sodium levels were signiﬁcantly lower in males given the
Cry2Ae protein compared to their controls (158.3  1.16 vs 160  0.94 mmol/L); in females given
the Cry2Ae protein, alkaline phosphatase activity (ALP) and urea concentrations were higher
compared to the control (ALP: 164.8  19.14 vs 148.4  14.21 IU/L; urea: 15.36  1.84 vs
12.77  1.68 mmol/L). The differences were minimal, not associated with changes in related
45 Dossier: Part I – Section 7.8.1.
46 The WG was concerned about the single-dose group used, the low dose tested (75 mg/kg body weight (bw) per day) the
absence of a vehicle control and the lack of a full set of pathology, including organ weights and histopathology.
47 OECD (Organisation for Economic Co-operation and Development), Test No. 407: Repeated Dose 28-day Oral Toxicity Study in
Rodents. OECD Guidelines for the Testing of Chemicals, Section 4.
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parameters (e.g. liver and kidney weights, gross pathology and histopathology) and were therefore
considered not toxicologically relevant by the GMO Panel. Signiﬁcantly decreased thymus weight was
found in males given the Cry2Ae protein compared to control males (0.0243  0.004 g vs
0.0288  0.003 g absolute weight; 0.1174  0.017 vs 0.1374  0.016% relative to body weight;
5.3735  0.875 vs 6.2993  0.703% relative to brain weight). The differences were minimal, not
associated with changes in related parameters (e.g. lymphocytes count, thymus histopathology) and
were therefore considered not toxicologically relevant by the GMO Panel. Macroscopic examinations at
necropsy revealed no gross pathological ﬁndings related to the treatment with the Cry2Ae protein.
Microscopic examinations of selected organs and tissues identiﬁed no treatment-related differences in
the incidence and severity of histopathological ﬁndings between the groups.
Regarding the lack of some parameters requested by OECD TG40747 (i.e. coagulation; bile acids),
the GMO Panel considered that the integrated assessment of available related parameters (e.g. platelet
count,48 total bilirubin, alanine aminotransferase (ALT) and aspartate transaminase (AST) activity, liver
weights, gross and histopathology) allowed to conclude in this study on coagulation and liver
toxicological assessment.
The GMO Panel concludes that no adverse effects were observed after a 28-day administration of
the Cry2Ae protein to mice at a dose of 1,000 mg/kg bw per day.
Toxicological assessment of new constituents other than proteins and/or changed levels of natural
constituents
No new constituents other than the Cry2Ae and PAT proteins are expressed in cotton GHB119 and
no relevant changes in the composition of the GM cotton were detected in the comparative
compositional analysis (see Section 3.2.1.3).
3.3.1.2. Animal studies with the food/feed derived from GM plants
a) Rat subchronic study49
In a subchronic, 13-week feeding study, spontaneously submitted by the applicant, four groups of
rats (strain Wistar Rj:WI (IOPS HAN), 10 male and 10 female animals per group) received diets
containing toasted cottonseed meal: (i) 5% meal derived from cotton GHB119 (supplemented with 5%
meal derived from the conventional counterpart, Coker 312), (ii) 10% meal from cotton GHB119, (iii)
10% meal from Coker 312 and (iv) 10% meal from commercial non-GM cotton (FM958), respectively.
Animals were housed in cages with ﬁve rats of the same gender per cage; however, in the
statistical analysis, the individual animal was considered as the experimental unit, ignoring any possible
bias due to cage interactions. Since the cage should be considered the experimental unit and due to
the low number of experimental units per treatment (two per sex), the GMO Panel did not consider
this study in its evaluation.
b) Chicken feeding study49
A total of 420 day-old Ross #708 broiler chickens of both genders was fed diets containing
approximately 5% of toasted cottonseed meal from cotton GHB119 (test group, conﬁrmed by PCR),
the non-GM near-isogenic cottonseed meal (Coker 31533, the conventional counterpart) and from a
non-GM commercial cottonseed (FiberMax 958), respectively, for 42 days. The birds were randomly
allocated by sex to pens (10 per cage), each treatment consisting of seven male pens and seven
female pens.
Overall, mortality (including three culled birds) was high (about 9%) with no signiﬁcant difference
between the groups, and during the study, a total of 103 out of 420 birds exhibited clinical symptoms
unrelated to treatment.23 In addition, the GMO Panel observed that the diets used in the study were
balanced with essential amino acids; e.g. the content of threonine and lysine in GM cottonseed diet
was doubled in the grower diet as compared with the counterpart cottonseed grower. Because of
these limitations, the GMO Panel could not use this study to conclude on the nutritional value of
cottonseed meal from cotton GHB119.
48 Tomlinson et al. (2013).
49 Dossier: Part I – Section 7.8.4; additional information: 4/7/2012.
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c) Northern bobwhite (Colinus virginianus) toxicity study50
The dietary toxicity study performed was based upon the US EPA OPPTS guideline 850.2200 (April
1996).51 and the OECD guideline 205 (April 1984).52 A total of 36 Northern bobwhite of indeterminate
gender, 11 days old at experimental start, was fed diets containing approximately 10% toasted
cottonseed meal from cotton GHB119 or 10% non-GM near-isogenic cottonseed meal from cotton
Coker 312 or a non-GM commercial diet, respectively, for 5 days, followed by a 3-day post-exposure
observation period where birds were fed the non-GM commercial diet only. This study was not
designed for the risk assessment of feeds; therefore, the GMO Panel could not consider it for the
nutritional evaluation or the assessment of potential unintended effects of cottonseed GHB119.
3.3.1.3. Allergenicity53
The strategies to assess the potential risk of allergenicity focus on the source of the recombinant
protein, on the potential of the newly expressed protein to induce sensitisation or to elicit allergic
reactions in already sensitised persons and on whether the transformation may have altered the
allergenic properties of the modiﬁed plant.
a) Assessment of allergenicity of the newly expressed protein54
A weight-of-evidence approach was followed, taking into account all of the information obtained on
the newly expressed protein, as no single piece of information or experimental method yield sufﬁcient
evidence to predict allergenicity (EFSA, 2006a; Codex Alimentarius, 2009; EFSA GMO Panel, 2011a).
The cry2Ae gene originates from B. thuringiensis subsp. kurstaki, a soil microorganism that is not
considered to be an allergenic source. The source of the bar gene encoding for the PAT protein is
S. hygroscopicus, which is also a soil microorganism and not considered to be an allergenic source.
Updated bioinformatic analyses55 of the amino acid sequences of the Cry2Ae and PAT proteins,
using the criterion of 35% identity in a sliding window of 80 amino acids, revealed no signiﬁcant
similarities to known allergens. In addition, the applicant performed analyses searching for matches of
eight contiguous identical amino acid sequences between the Cry2Ae and PAT proteins and known
allergens, which conﬁrmed the outcome of the previous bioinformatic analysis.
The studies on resistance to degradation of the Cry2Ae and PAT proteins by pepsin have been
described in Section 3.3.1.1.
The GMO Panel has previously evaluated the safety of the PAT protein in the context of several
applications and no concerns on allergenicity were identiﬁed (e.g. EFSA, 2006c; EFSA GMO Panel, 2013).
There is no information available on the structure or function of the newly expressed Cry2Ae
protein that would suggest an adjuvant effect due to its presence in cotton GHB119 resulting in or
increasing an eventual immunoglobulin E (IgE) response to a bystander protein.
In the context of the present application, the GMO Panel considers that there are no indications
that the newly expressed Cry2Ae and PAT proteins individually, or their simultaneous presence, in
cotton GHB119 may be allergenic.
b) Assessment of allergenicity of GM plant products
The GMO Panel regularly reviews the available publications on food allergy to cottonseed (EFSA GMO Panel,
2016). However, to date, cotton has not been considered to be a common allergenic food56 (OECD, 2009).
Therefore, the GMO Panel did not request experimental data to analyse the allergen repertoire of GM cotton.
In the context of this application and considering the data from the molecular characterisation, the
compositional analysis and the assessment of the newly expressed proteins (see Sections 3.1.1, 3.2.1
50 Dossier: Part I – Section 7.8.4.
51 United States Environmental Protection Agency, 1996 Ofﬁce of Prevention, Pesticides and Toxic Substances. Ecological Effects
Test Guideline, OPPTS 850.2200. Avian Dietary Toxicity Test. April 1996. US Environmental Protection Agency, Washington, DC.
52 OECD (Organisation for Economic Co-operation and Development), 1984 OECD Guidelines for Testing of Chemicals, 205, Avian
Dietary Toxicity Test. 10 pp.
53 Dossier: Part I – Section D7.9.
54 Dossier: Part I – Section D7.9.1; additional information: 11/11/2015, 2/3/2015 and 13/3/2013.
55 Additional information: 16/6/2016.
56 Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food
information to consumers, amending Regulations (EC) No 1924/2006 and (EC) No 1925/2006 of the European Parliament and
of the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/
EC, Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC
and Commission Regulation (EC) No 608/2004.
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and 3.3.1.1), the GMO Panel identiﬁed no indications of a potentially increased allergenicity of food
and feed derived from cotton GHB119 with respect to that derived from its conventional counterpart.
3.3.1.4. Nutritional assessment of GM food/feed57,58
The intended trait of cotton GHB119 is insect resistance and herbicide tolerance, with no intention to
alter the nutritional parameters. The outcome of the compositional analysis (see Section 3.2.1.3) indicated
that the introduction of food and feed products derived from cotton GHB119 into the food and feed supply
is expected to have no adverse nutritional impact, as compared to its conventional counterpart.
The compositional data identiﬁed lower crude protein content in the GM cotton GHB119 compared
to its conventional counterpart (Section 3.2.1.3, Tables 3 and 4). The main product for human
consumption derived from cottonseed is the oil. Oil is not considered a source of protein for human
nutrition, being almost devoid of protein contents. Products from cottonseed other than oil might be
used for human consumption (e.g. processed linter pulp, ﬁbre) generally in very small amount (OECD,
2009). The GMO Panel considers the lower crude protein content of the oil and of other products
derived from cotton GHB119 to be of no concern as regards human nutrition. The GMO
Panel considered the lower crude protein content in the GM cotton GHB119 of no safety concern, since
a proper diet formulation can balance this endpoint.
The compositional data identiﬁed lower total tocopherol levels in seeds from cotton GHB119 compared
to its conventional counterpart (101.7 and 107.0 mg/kg DM in cottonseeds from cotton GHB119, treated
and not treated with the intended herbicides, respectively; 114.0 mg/kg DM in the conventional
counterpart, Table 4). Detailed oil compositional analysis showed that the pattern of tocopherol fractions
from cotton GHB119 oil is similar to that of the conventional counterpart, including a-tocopherol
content.59 Tocopherol content is a relevant quality parameter for vegetable oils including cottonseed oil.
The GMO Panel considers that the changes in total tocopherol concentration in cotton GHB119 seeds are
not of concern for human nutrition. The GMO Panel considered the lower total tocopherol levels in seeds
from cotton GHB119 of no safety concern, since animal complete feeds are balanced with vitamins.
The GMO Panel concludes that cotton GHB119 is as nutritious as its conventional counterpart.
3.3.1.5. Post-market monitoring of GM food/feed
No biologically relevant compositional, agronomic and phenotypic changes were identiﬁed in cotton
GHB119 when compared with its conventional counterpart. Furthermore, the overall intake or exposure
is not expected to change because of the introduction of cotton GHB119 into the market. The GMO
Panel therefore considers cotton GHB119 to be as safe as its conventional counterpart and that PMM
(EFSA, 2006a; EFSA GMO Panel, 2011a) of the food/feed derived from cotton GHB119 is not necessary.
3.3.2. Conclusion
The safety assessment identiﬁed no concerns regarding the potential toxicity or allergenicity of the
newly expressed Cry2Ae and PAT proteins in cotton GHB119, and found no indications of a potentially
increased allergenicity of cotton GHB119 with respect to non-GM cotton. Based on the results of
comparative analysis and on the nutritional assessment of crude protein and tocopherol content, the
nutritional characteristics of food and feed derived from cotton GHB119 are not expected to differ from
that of food and feed derived from non-GM cotton varieties, and therefore the GMO Panel concludes
that cotton GHB119 is as safe and nutritious as its conventional counterpart.
3.4. Environmental risk assessment and monitoring plan
3.4.1. Evaluation of relevant scientiﬁc data
Considering the scope of application EFSA-GMO-NL-2011-96 (which excludes cultivation), the
environmental risk assessment (ERA) of cotton GHB119 is mainly concerned with: (1) the exposure of
bacteria to recombinant DNA in the gastrointestinal tract of animals fed GM material and bacteria
present in the environments exposed to their faecal material (manure and faeces); and (2) the
accidental release into the environment of viable cottonseeds GHB119 during transportation and
processing (EFSA GMO Panel, 2010).
57 Dossier: Part I – Section D7.2.5.
58 Additional information: 3/2/2015.
59 Dossier: Part I – Section D7.2.5; additional information: 28/6/2016 and 25/8/2016.
Scientiﬁc opinion on GM cotton GHB119
www.efsa.europa.eu/efsajournal 19 EFSA Journal 2016;14(10):4586
3.4.1.1. Environmental risk assessment
Persistence and invasiveness of the GM plant18
In southern Europe, Gossypium herbaceum and G. hirsutum have been grown since the 19th
century and led to transient or locally naturalised cotton plants in the same area (Davis, 1967; Tutin
et al., 1992; Sarno et al., 1993; Celesti-Grapow et al., 2010). However, survival of cottonseeds outside
cultivation areas in Europe is limited due to the absence of a seed dormancy phase. Even if seeds from
spillage germinate, the resulting cotton plants are unlikely to survive due to factors such as cold
climatic conditions, the susceptibility to diseases and their low competitiveness (Eastick and Hearnden,
2006). For example, after the end of cotton cultivation in Italy in 1950s, no feral cotton was reported
in southern Italy, except in some restricted areas (Sarno et al., 1993; Celesti-Grapow et al., 2010).
Also in other cotton-growing regions, such as in Australia, surveys showed that feral GM cotton
established infrequently along transportation routes and mostly as transient populations (Addison
et al., 2007).
Cotton GHB119 has been developed for protection against certain lepidopteran pests, such as the
CBW (H. zea), TBW (H. virescens) and FAW (S. frugiperda), and tolerance to glufosinate ammonium-
based herbicides. The increased resistance against cotton insect pests due to the expression of the
cry2Ae gene may provide a selective advantage in situations where plant survival is affected by pest
pressure. Also, the pat gene coding for the herbicide tolerance trait can provide a potential agronomic
and selective advantage for this GM cotton plant when glufosinate ammonium-based herbicides are
applied. However, in case of accidental release into the environment of viable cottonseeds GHB119
during transportation and processing, establishment and survival of this GM cotton in the EU is limited
by the biotic and abiotic factors described above.
As described in Section 3.2.1.2, GM cotton GHB119 treated with glufosinate ammonium-based
herbicides and treated with conventional herbicides differed from its conventional counterpart in plant
height, number of developed nodes, ﬁrst bolls position, plant emergence, days until ﬂowering, days
until boll formation, seed number and weight and for seed and ﬁbre yield. GM cotton GHB119
conventionally treated and treated with glufosinate ammonium-based herbicides differed from its
conventional counterpart also for several ﬁbre characteristics and, as expected, in biotic interactions,
due to the expression of the toxic protein (Cry2Ae). Considering the biology of cotton, the differences
observed in agronomic and phenotypic characteristics are unlikely to be biologically relevant in terms
of increased ﬁtness potential. In order to investigate additional characteristics of the GM cotton
indicative of changes in survival, pollen morphology and germination were investigated, as well as the
overwinter capacity of the cottonseeds GHB119. The conducted studies did not identify differences
between the GM cotton and its conventional counterpart.
In the case of accidental release into the environment of cotton GHB119, there are no indications
of an increased likelihood of establishment and spread of occasional feral cotton GHB119 plants.
Should these plants be exposed to glufosinate ammonium-based herbicides, they are likely to exhibit a
selective advantage that could increase their transient local occurrence. However, this will not result in
different environmental impacts compared to conventional cotton.
In addition to the data presented by the applicant, the GMO Panel is not aware of any scientiﬁc
report of increased spread and establishment of GM cotton GHB119 in regions where it is cultivated,
and of any change in survival capacity, including overwintering.
The GMO Panel concludes that it is very unlikely that cotton GHB119 will differ from conventional
cotton varieties in its ability to survive or establish feral populations under European environmental
conditions.
Effects of gene transfer60
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic
material, either through horizontal gene transfer of DNA, or through vertical gene ﬂow via seed
dispersal and cross-pollination from feral plants originating from spilled seeds.
a) Plant-to-bacteria microorganism gene transfer
Genomic DNA is a component of many food and feed products derived from cotton. It is well
documented that DNA present in food and feed becomes substantially degraded during processing and
digestion in the human or animal gastrointestinal tract. However, a low level of exposure of fragments
60 Dossier: Part I – Section D6.
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of ingested DNA, including the recombinant fraction of such DNA, to bacteria in the digestive tract of
humans, domesticated animals and other environments exposed to the GM plant or plant material is
expected. Current scientiﬁc knowledge of recombination processes in bacteria suggests that horizontal
transfer of non-mobile, chromosomally located DNA fragments between unrelated organisms (such as
from plants to bacteria) is not likely to occur at detectable frequencies under natural conditions (for
further details, see EFSA, 2009).
A successful horizontal gene transfer would require stable insertion of the recombinant DNA
sequences into a bacterial genome and a selective advantage to be conferred to the transformed host.
The only mechanism known to facilitate horizontal transfer of non-mobile, chromosomal DNA
fragments to bacterial genomes is homologous recombination. This requires the presence of stretches
of DNA sequences that are similar in the recombining DNA molecules. The similarity between the plant
and bacterial sequences can be situated in the coding region of a recombinant protein (transgene) or
in the border regions of the recombinant gene cassettes inserted into the plant genome. In the case of
sequence identity with the transgene itself, recombination would result in gene replacement. In the
case of identity with border regions, recombination could result in the insertion of additional DNA
sequences in bacteria and thus confer the potential for new properties.
Cotton GHB119 contains genetic elements with identity or high similarity to those of bacteria. These
are the coding sequence of cry2Ae, a codon-optimised sequence of cry2Ae from B. thuringiensis, and
the coding sequence of the phosphinothricin acetyltransferase (bar) gene of S. hygroscopicus with a
minor modiﬁcation. The ﬂanking regions of the recombinant gene insert contain approximately 20 bp
long sequences of the truncated right and left border of the Ti-plasmid of A. tumefaciens. Both species,
B. thuringiensis and S. hygroscopicus, are not considered to be prevalent in the main receiving
environment, i.e. the gastrointestinal tract of humans or animals. Both occur in soil and, in addition,
B. thuringiensis has been frequently isolated from the guts of insects (Jensen et al., 2003). However,
occurrence of the recombinant genes outside their immediate receiving environment in the habitats of
both bacterial species cannot be ruled out (Hart et al., 2009) and is therefore also considered here.
On a theoretical basis (i.e. without any study providing experimental evidence for horizontal gene
transfer (HGT) in the case of GM food and feed derived from cotton GHB119 or any other GM plant), it can
be assumed that, as an extremely rare event, homologous recombination can occur between the
recombinant bar gene and its natural variant in S. hygroscopicus or other Actinobacteria. Such
recombination events would only replace natural variants (substitutive recombination) and are therefore
are unlikely to provide any new property connected to a selective advantage for the recipient organisms
(EFSA, 2009). The cry2Ae gene, being codon optimised, has insufﬁcient similarity to known corresponding
bacterial genes to facilitate homologous recombination between GM cotton and environmental bacteria.
Double homologous recombination of the ﬂanking regions with those on Ti-plasmids of
A. tumefaciens were not considered because the 20 bp ﬂanking regions for the Ti-plasmid would not
be of sufﬁcient lengths to facilitate double homologous recombination.
In addition to homology-based recombination processes, illegitimate recombination that does not
require DNA similarity between the recombining DNA molecules is theoretically possible. However, the
transformation rates for illegitimate recombination are considered to be 1010-fold lower than for
homologous recombination (H€ulter and Wackernagel, 2008; EFSA, 2009). Illegitimate recombination
events have not been detected in studies that have exposed bacteria to high concentrations of GM plant
DNA (EFSA, 2009). Thus, this process, in comparison with homologous recombination, is not considered
to be a minimal contributor to HGT events. In comparison with the above-described homology-facilitated
recombination processes, the contribution of illegitimate recombination is extremely low.
The GMO Panel concludes that the bar gene from cotton GHB119 may, on a theoretical basis,
replace similar genes by homologous recombination with environmentally present S. hygroscopicus or
other Actinobacteria with corresponding genes. Such a transfer would not provide a new selective
advantage to the recipients. Codon optimisation altered the cry2Ae gene so that homologous
recombination with corresponding bacterial genes would not be facilitated. Thus, considering the scope
of this application, the GMO Panel has not identiﬁed any concern associated with HGT from cotton
GHB119 to bacteria.
b) Plant-to-plant gene transfer
Considering the scope of application EFSA-GMO-NL-2011-96 and the biology of cotton, a pathway
to possible harm pertains to the potential of occasional feral GM cotton plants originating from
accidental spillage of imported cottonseed GHB119 to transfer recombinant DNA to sexually cross-
compatible plants.
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Cotton is predominantly an annual self-pollinating crop, although cross-pollination can occur at low
frequencies in the presence of insect pollinators (such as wild bees, honeybees, bumblebees) (OECD,
2008).
The extent of cross-pollination will mainly depend on the scale of accidental release during
transportation and processing, and the successful establishment and subsequent ﬂowering of GM
cotton plants. For cotton, no wild relatives have been reported in Europe, therefore any vertical gene
transfer is limited to cultivated (G. hirsutum and G. herbaceum) and feral cotton plants. However, gene
transfer to G. herbaceum is considered unlikely due to the difference in ploidy level.
The occurrence of feral GM cotton is expected to be limited. For plant-to-plant gene transfer to
occur, imported cottonseeds need to be processed outside the importing ports, transported into
regions of cotton production in Europe, spilled during transportation, germinate and develop into
plants in the very close vicinity of cotton ﬁelds, and there needs to be an overlap of ﬂowering periods
and environmental conditions favouring cross-pollination. It must be noted that most cottonseeds are
processed in the countries of production or in ports of importation.
In conclusion, the GMO Panel considers that the likelihood of environmental effects as a
consequence of the spread of genes from cotton GHB119 in Europe will not differ from that of
conventional cotton, even after exposure to glufosinate ammonium-based herbicides.
Interactions of the GM plant with target organisms61
Considering the scope of application EFSA-GMO-NL-2011-96, potential interactions of occasional
feral cotton GHB119 plants arising from seed import spills with target organisms are not considered a
relevant issue by the GMO Panel.
Interactions of the GM plant with non-target organisms62
Considering the scope of application EFSA-GMO-NL-2011-96 and the low level of exposure to the
environment, potential interactions of the GM cottonseeds or plants arising from spillage of imported
seeds with non-target organisms were not considered a relevant issue by the GMO Panel.
The GMO Panel evaluated whether the expressed Cry2Ae protein might potentially affect non-target
organisms by entering the environment through faecal material of animals fed GM cottonseed
products. Cry proteins are degraded by enzymatic activity in the gastrointestinal tract, meaning that
only low amounts of Cry proteins would remain intact to pass out in faeces to the soil. This was
demonstrated for Cry1Ab (Einspanier et al., 2004; Lutz et al., 2005, 2006; Wiedemann et al., 2006;
Guertler et al., 2008; Paul et al., 2010). Further degradation of the proteins in the manure and faeces
would take place because of microbiological proteolytic activity. In addition, there would be further
degradation of Cry proteins in soil, reducing the possibility for exposure of potentially sensitive non-
target organisms. Although Cry proteins may bind to clay minerals and organic substances in soil,
thereby reducing their availability to microorganisms for degradation, there are no indications of
persistence and accumulation of Cry proteins from GM crops in soil (Gruber et al., 2011; Valldor et al.,
2015). The GMO Panel is not aware of evidence of released Cry proteins from GM plants causing
signiﬁcant negative effects on soil microorganisms.
Considering the scope of the application, it can be concluded that the exposure of potentially
sensitive non-target organisms to the Cry2Ae protein is likely to be very low and of no biological
relevance.
Interactions with the abiotic environment and biochemical cycles63
Considering the scope of application EFSA-GMO-NL-2011-96, and the low level of exposure to the
environment, potential interactions with the abiotic environment and biogeochemical cycles were not
considered a relevant issue by the GMO Panel.
3.4.2. Post-market environmental monitoring64
The objectives of a post-market environmental monitoring (PMEM) plan, according to Annex VII of
Directive 2001/18/EC, are (1) to conﬁrm that any assumption regarding the occurrence and impact of
potential adverse effects of the GMO, or its use, in the ERA are correct and (2) to identify the
61 Dossier: Part I – Section D8 and D9.4.
62 Dossier: Part I – Section D9.5.
63 Dossier: Part I – Section D9.8 and D10.
64 Dossier: Part I – Section D11.
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occurrence of adverse effects of the GMO, or its use, on human health or the environment that were
not anticipated in the ERA.
Monitoring is related to risk management, and thus, a ﬁnal adoption of the PMEM plan falls outside
the mandate of EFSA. However, the GMO Panel gives its opinion on the scientiﬁc content of the PMEM
plan provided by the applicant (EFSA, 2006b; EFSA GMO Panel, 2011b). The potential exposure to the
environment of cotton GHB119 would be through faecal material from animals fed the GM cotton or
through accidental release into the environment of viable GM cotton seeds during transportation and
processing.
The PMEM plan proposed by the applicant includes (1) the description of an approach involving
operators (federations involved in cotton import and processing) reporting any observed adverse effect
(s) of the GMO on human health and the environment to the applicants via a centralised system; (2) a
coordinating system established by EuropaBio for the collection of the information recorded by the
various operators; and (3) the use of networks of existing surveillance systems (Lecoq et al., 2007;
Windels et al., 2008). The applicant proposes to submit a PMEM report on an annual basis and a ﬁnal
report at the end of the consent period.
The GMO Panel is of the opinion that the PMEM plan proposed by the applicant is in line with the
scope of application EFSA-GMO-NL-2011-96. As no potential adverse environmental effects were
identiﬁed, case-speciﬁc monitoring was not considered necessary. The GMO Panel agrees with the
reporting intervals proposed by the applicant in its PMEM plan.
3.4.3. Conclusion
No safety concerns with regard to the environment from the import and processing of cotton
GHB119 were identiﬁed. There are no indications of an increased likelihood of the establishment and
spread of occasional feral cotton GHB119 plants in the case of accidental release into the environment
of viable GM cottonseeds even when exposed to glufosinate ammonium-based herbicides. The unlikely,
but theoretically possible, horizontal transfer of recombinant genes from cotton GHB119 to bacteria
does not raise any environmental safety concern. Considering the scope of the application, potential
interactions of cotton GHB119 with the biotic and abiotic environment were not considered a relevant
issue by the GMO Panel. The scope of the PMEM plan provided by the applicant and the reporting
intervals are in line with the intended uses of cotton GHB119 and the GMO Panel guidelines on the
post-market environmental monitoring of GM plants (EFSA, 2006b, EFSA GMO Panel, 2011b).
4. Overall conclusions and recommendations
The GMO Panel was asked to carry out a scientiﬁc assessment of cotton GHB119 for import,
processing, and food and feed uses in accordance with Regulation (EC) No 1829/2003.
The molecular characterisation data establish that cotton GHB119 contains a single insert consisting
of a single copy of the T-DNA containing the cry2Ae and the bar expression cassettes. No other parts
of the plasmid used for transformation are present in cotton GHB119. Bioinformatic analyses and
genetic stability studies did not raise safety issues. The levels of the Cry2Ae and PAT proteins in cotton
GHB119 have been sufﬁciently analysed.
The safety assessment identiﬁed no concerns regarding the potential toxicity or allergenicity of the
newly expressed Cry2Ae and PAT proteins in cotton GHB119, and found no indications of a potentially
increased allergenicity of cotton GHB119 with respect to non-GM cotton. Based on the results of
comparative analysis and on the nutritional assessment of crude protein and tocopherol content, the
nutritional characteristics of food and feed derived from cotton GHB119 are not expected to differ from
that of food and feed derived from non-GM cotton varieties. The GMO Panel concludes that cotton
GHB119 is as safe and nutritious as its conventional counterpart. The GMO Panel considers that PMM
of food/feed derived from cotton GHB119 is not necessary, given the absence of safety concerns
identiﬁed.
Considering the scope of cotton GHB119, which excludes cultivation, there is no requirement for a
scientiﬁc assessment of possible environmental effects associated with the cultivation of this GM
cotton. In the case of accidental release into the environment of viable seeds of cotton GHB119 (e.g.
during transport and processing), there are no indications of an increased likelihood of establishment
and spread of feral cotton plants. The low level of environmental exposure of these GM cotton plants
indicates that the risk to non-target organisms is extremely low. In the context of its intended uses,
the unlikely but theoretically possible transfer of the recombinant gene from cotton GHB119 to
environmental bacteria does not raise safety concern owing to the lack of a selective advantage which
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would be conferred. The scope of the PMEM plan provided by the applicant and the reporting intervals
are in line with the intended uses of cotton GHB119 and the guidance document of the GMO Panel on
post-market environmental monitoring of GM plants (EFSA GMO Panel, 2011b).
In conclusion, the GMO Panel considers that the information available for cotton GHB119 addresses
the scientiﬁc comments raised by the Member States and that cotton GHB119, as described in this
application, is as safe as its conventional counterpart with respect to potential effects on human and
animal health and the environment in the context of the scope of this application.
Documentation provided to EFSA
1) Letter from the Competent Authority of The Netherlands received on 7 April 2011
concerning a request for the placing on the market of genetically modiﬁed cotton GHB119
submitted under Regulation (EC) No 1829/2003 by Bayer CropScience AG (EFSA reference
EFSA-GMO-NL-2011-96).
2) Acknowledgement letter dated 27 April 2011 from EFSA to the Competent Authority of the
Netherlands.
3) Letter from EFSA to the applicant dated 26 May 2011 requesting additional information
under completeness check.
4) Letter from the applicant received on 30 August 2011 providing additional information
under completeness check.
5) Letter from EFSA to the applicant dated 19 September 2011 requesting additional
information under completeness check.
6) Letter from the applicant received on 31 October 2011 providing additional information
under completeness check.
7) Letter from EFSA to the applicant dated 21 November 2011 delivering the ‘Statement of
Validity’ of application EFSA-GMO-NL-2011-96 for the placing on the market of genetically
modiﬁed cotton GHB119 submitted under Regulation (EC) No 1829/2003 by Bayer
CropScience AG.
8) Letter from the applicant received on 25 November 2011 providing EFSA with an updated
version of the application EFSA-GMO-NL-2011-96 submitted under Regulation (EC)
No 1829/2003 by Bayer CropScience AG.
9) Letter from EFSA to the applicant dated 14 February 2012 requesting additional
information and stopping the clock.
10) Letter from EFSA to applicant dated 17 April 2012 requesting additional information and
maintaining the clock stopped.
11) Letter from applicant to EFSA received on 21 May 2012 providing additional information.
12) Letter from the applicant to EFSA received on 4 July 2012 providing additional information.
13) Letter from EFSA to the applicant dated 9 January 2013 re-starting the clock.
14) Letter from EFSA to the applicant dated 11 February 2013 requesting additional
information and stopping the clock.
15) Letter from EFSA to the applicant dated 22 February 2013 requesting additional
information and maintaining the clock stopped.
16) Corrigendum letter from EFSA to the applicant dated 28 February 2013 requesting
complementary information and maintaining the clock stopped.
17) Letter from applicant to EFSA received on 13 March 2013 providing additional information.
18) Letter from applicant to EFSA received on 5 April 2013 providing additional information.
19) Letter from EFSA to the applicant dated 24 July 2013 requesting additional information and
maintaining the clock stopped.
20) Letter from applicant to EFSA received on 2 March 2015 providing additional information.
21) Letter from EFSA to the applicant dated 24 June 2015 requesting additional information
and maintaining the clock stopped.
22) Letter from applicant to EFSA received on 9 July 2015 providing additional information.
23) Letter from EFSA to the applicant dated 5 October 2015 requesting additional information
and maintaining the clock stopped.
24) Letter from EFSA to the applicant dated 12 October 2015 requesting additional information
and maintaining the clock stopped.
25) Letter from applicant to EFSA received on 11 November 2015 providing additional
information.
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26) Letter from EFSA to the applicant dated 26 November 2015 requesting additional
information and maintaining the clock stopped.
27) Letter from applicant to EFSA received on 30 November 2015 providing additional
information.
28) Letter from applicant to EFSA received on 23 December 2015 providing additional
information.
29) Letter from EFSA to the applicant dated 16 February 2016 requesting additional
information and maintaining the clock stopped.
30) Letter from applicant to EFSA received on 4 April 2016 providing additional information.
31) Email from EFSA to applicant dated 5 April 2016 re-starting the clock from 4 April 2016.
32) Letter from EFSA to the applicant dated 7 April 2016 requesting additional information and
stopping the clock.
33) Letter from EFSA to the applicant dated 13 June 2016 requesting additional information
and maintaining the clock stopped.
34) Letter from applicant to EFSA received on 16 June 2016 providing additional information.
35) Letter from applicant to EFSA received on 29 June 2016 providing additional information.
36) Email from EFSA to applicant dated 30 June 2016 re-starting the clock from 29 June 2016.
37) Letter from EFSA to the applicant dated 3 August 2016 requesting additional information
and stopping the clock.
38) Letter from applicant to EFSA received on 25 August 2016 providing additional information.
39) Email from EFSA to applicant dated 26 August 2016 re-starting the clock from 25 August
2016.
References
Addison SJ, Farrell T, Roberts GN and Rogers DJ, 2007. Roadside surveys support predictions of negligible
naturalisation potential for cotton (Gossypium hirsutum) in north-east Australia. Weed Research, 47, 192–201.
Barrow JR, 1981. A new concept in assessing cotton pollen germinability. Crop Science, 21, 441–443.
Berberich SA, Ream JE, Jackson TL, Wood R, Stipanovic R, Harvey P, Patzer S and Fuchs RL, 1996. The
composition of insect-protected cottonseed is equivalent to that of conventional cottonseed. Journal of
Agricultural and Food Chemistry, 44, 365–371.
Celesti-Grapow L, Pretto F, Carli E and Blasi C (eds)., 2010. Flora vascolare alloctona e invasiva delle regioni
d’Italia. Casa Editrice Universita La Sapienza, Rome, Italy, 208 pp.
Codex Alimentarius, 2009. Foods Derived from Modern Biotechnology. Codex Alimentarius Commission, Joint
FAO/WHO Food Standards Programme, Rome, Italy, 85 pp.
Davis PH, 1967. Flora of Turkey and the East Aegean Islands Vol. 2. Edinburgh University Press, Edinburgh, 581 pp.
Eastick RJ and Hearnden MN, 2006. Potential for weediness of Bt cotton in northern Australia. Weed Science, 54,
1142–1151.
EFSA (European Food Safety Authority), 2006a. Guidance document of the Scientiﬁc Panel on Genetically Modiﬁed
Organisms for the risk assessment of genetically modiﬁed plants and derived food and feed. EFSA Journal
2006;4(4):99, 100 pp. doi:10.2903/j.efsa.2006.99
EFSA (European Food Safety Authority), 2006b. Opinion of the Scientiﬁc Panel on Genetically Modiﬁed Organisms
on the Post Market Environmental Monitoring (PMEM) of genetically modiﬁed plants. EFSA Journal 2006;
4(3):319, 27 pp. doi:10.2903/j.efsa.2006.319
EFSA (European Food Safety Authority), 2006c. Opinion of the Scientiﬁc Panel on Genetically Modiﬁed Organisms
on an application (Reference EFSA-GMO-NL-2005-13) for the placing on the market of glufosinate-tolerant
genetically modiﬁed LLCotton25, for food and feed uses, and import and processing under Regulation (EC) No
1829/2003 from Bayer CropScience. EFSA Journal 2006;4(12):429, 19 pp. doi:10.2903/j.efsa.2006.429
EFSA (European Food Safety Authority), 2009. Consolidated presentation of the joint Scientiﬁc Opinion of the GMO
and BIOHAZ Panels on the “Use of Antibiotic Resistance Genes as Marker Genes in Genetically Modiﬁed Plants”
and the Scientiﬁc Opinion of the GMO Panel on “Consequences of the Opinion on the Use of Antibiotic
Resistance Genes as Marker Genes in Genetically Modiﬁed Plants on Previous EFSA Assessments of Individual
GM Plants”. EFSA Journal, 2009;7(6):1108, 107 pp. doi:10.2903/j.efsa.2009.1108
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2010. Guidance on the environmental risk
assessment of genetically modiﬁed plants. EFSA Journal 2010;8(11):1879, 111 pp. doi:10.2903/j.efsa.2010.1879
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2011a. Scientiﬁc Opinion on Guidance for risk
assessment of food and feed from genetically modiﬁed plants. EFSA Journal 2011;9(5): 2150, 37 pp.
doi:10.2903/j.efsa.2011.2150
Scientiﬁc opinion on GM cotton GHB119
www.efsa.europa.eu/efsajournal 25 EFSA Journal 2016;14(10):4586
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2011b. Scientiﬁc Opinion on guidance on the
Post-Market Environmental Monitoring (PMEM) of genetically modiﬁed plants. EFSA Journal 2011;9(8):2316,
40 pp. doi:10.2903/j.efsa.2011.2316
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2013. Scientiﬁc Opinion on application
EFSA-GMO-NL-2011-97 for the placing on the market of insect-resistant and herbicide-tolerant genetically
modiﬁed cotton T304-40 for food and feed uses, import and processing under Regulation (EC) No 1829/2003
from Bayer CropScience AG. EFSA Journal 2013;11(6):3251, 31 pp. doi:10.2903/j.efsa.2013.3251
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2016. Scientiﬁc Opinion on an application by
Dow Agrosciences LLC (EFSA-GMO-NL-2009-68) for placing on the market of cotton 281-24-236 x 3006-210-23
x MON 88913 for food and feed uses, import and processing under Regulation (EC) No 1829/2003. EFSA
Journal 2016;14(4):4430, 21 pp. doi:10.2903/j.efsa.2016.4430
Einspanier R, Lutz B, Rief S, Berezina O, Zverlov V, Schwarz W and Mayer J, 2004. Tracing residual recombinant
feed molecules during digestion and rumen bacterial diversity in cattle fed transgene maize. European Food
Research and Technology, 218, 269–273.
Forster LA and Calhoun MC, 1995. Nutrient values for cottonseed product deserve new look. Feedstuffs, 67, 1–5.
Gruber H, Paul V, Meyer HDH and M€uller M, 2011. Determination of insecticidal Cry1Ab protein in soil collected in
the ﬁnal growing seasons of a nine-year ﬁeld trial of Bt maize MON810. Transgenic Research, 21, 77–88.
Guertler P, Lutz B, Kuehn R, Meyer HHD, Einspanier R, Killermann B and Albrecht C, 2008. Fate of recombinant
DNA and Cry1Ab protein after ingestion and dispersal of genetically modiﬁed maize in comparison to rapeseed
by fallow deer (Dama dama). European Journal of Wildlife Research, 54, 36–43.
Hart MM, Powell JR, Gulden RH, Levy-Booth DJ, Dunﬁeld KE, Pauls KP, Swanton CJ, Klironomos JN and Trevors JT,
2009. Detection of transgenic cp4 epsps genes in the soil food web. Agronomy for Sustainable Development,
29, 497–501.
H€ulter N and Wackernagel W, 2008. Double illegitimate recombination events integrate DNA segments through
two different mechanisms during natural transformation of Acinetobacter baylyi. Molecular Microbiology, 67,
984–995.
Jensen GB, Hansen BM, Eilenberg J and Mahillon J, 2003. The hidden lifestyles of Bacillus cereus and relatives.
Environmental Microbiology, 5, 631–640.
Lecoq E, Holt K, Janssens J, Legris G, Pleysier A, Tinland B and Wandelt C, 2007. General surveillance: roles and
responsibilities – the industry view. Journal of Consumer Protection and Food Safety, 2, 25–28.
Lutz B, Wiedemann S, Einspanier R, Mayer J and Albrecht C, 2005. Degradation of Cry1Ab protein from genetically
modiﬁed maize in the bovine gastrointestinal tract. Journal of Agricultural and Food Chemistry, 53, 1453–1456.
Lutz B, Wiedemann S and Albrecht C, 2006. Degradation of transgenic Cry1Ab DNA and protein in Bt-176 maize
during the ensiling process. Journal of Animal Physiology and Animal Nutrition, 90, 116–123.
OECD (Organisation for Economic Co-operation and Development), 2008. Consensus document on the biology of
cotton (Gossypium spp.). Series on Harmonisation of Regulatory Oversight in Biotechnology, No 45. ENV/JM/
MONO(2008)33.
OECD (Organisation for Economic Co-operation and Development), 2009. Consensus document on compositional
considerations for new varieties of cotton (Gossypium hirsutum and Gossypium barbadense): key food and
feed nutrients and anti-nutrients. Series on the Safety of Novel Foods and Feeds, No 11. ENV/JM/MONO(2004)
16. http://www.oecd.org/dataoecd/16/42/46815236.pdf.
Paul V, Guertler P, Wiedemann S and Meyer HHD, 2010. Degradation of Cry1Ab protein from genetically modiﬁed maize
(MON810) in relation to total dietary feed proteins in dairy cow digestion. Transgenic Research, 19, 683–689.
Sarno R, Poma I and Davi A, 1993. Evaluation of cotton cultivar (Gossypium spp.) in the Western Sicily. Available
online: http://agris.fao.org/agris-search/search.do?recordID=IT9461038
Tomlinson L, Boone LI, Ramaiah L, Penraat KA, von Beust BR, Ameri M, Poitout-Belissent FM, Weingand K,
Workman HC, Aulbach AD, Meyer DJ, Brown DE, MacNeill AL, Provencher Bolliger A and Bounous DI, 2013.
Best practices for veterinary toxicologic clinical pathology, with emphasis on the pharmaceutical and
biotechnology industries. Veterinary Clinical Pathology, 42, 252–269.
Tutin TG, Heywood VH, Burges NA, Valentine DH, Walters SM and Webb DA, 1992. Flora Europaea, Vol. 2, 5th
reprint. Cambridge University Press, Cambridge, UK. 469 pp.
Valldor P, Miethling-Graff R, Martens R and Tebbe CC, 2015. Fate of the insecticidal Cry1Ab protein of GM crops in
two agricultural soils as revealed by 14C-tracer studies. Applied Microbiology and Biotechnology, 99, 7333–7341.
Wiedemann S, Lutz B, Kurtz H, Schwarz FJ and Albrecht C, 2006. In situ studies on the time-dependent degradation
of recombinant corn DNA and protein in the bovine rumen. Journal of Animal Science, 84, 135–144.
Windels P, Alcalde E, Lecoq E, Legris G, Pleysier A, Tinland B and Wandelt C, 2008. General surveillance for import
and processing: the EuropaBio approach. Journal of Consumer Protection and Food Safety, 3, 14–16.
Abbreviations
AA amino acid
aadA aminoglycoside adenyltransferase
ADF acid detergent ﬁbre
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ALP alkaline phosphatase
ALT alanine aminotransferase
ANOVA analysis of variance
AST aspartate transaminase
ATCC American Type Culture Collection
CBW cotton bollworm
DM dry matter
ELISA enzyme-linked immunosorbent assay
ERA environmental risk assessment
FA fatty acid
FAW fall armyworm larvae
FW fresh weight
GLP Good Laboratory Practice
GM genetically modiﬁed
GMO Genetically Modiﬁed Organisms
GMO Panel EFSA Panel on Genetically Modiﬁed Organisms
HGT horizontal gene transfer
IgE immunoglobulin E
NDF neutral detergent ﬁbre
OECD Organisation for Economic Co-operation and Development
ORF open reading frame
PAT phosphinothricin acetyltransferase
PCR polymerase chain reaction
PMEM post-market environmental monitoring
PMM post-market monitoring
RBD reﬁned bleached deodorised
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis
TBW tobacco budworm
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